Andrea Melloni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrea Melloni has a total of 207 co-authors. Here are the top co-authors by number of shared publications:
- Luca Bertoglio
Division of Vascular Surgery, Department of Surgical and Clinical Sciences, University and ASST Spedali Civili Hospital of Brescia, Brescia, Italy
15 shared publications Roberto Chiesa
9 shared publications- Andrea Kahlberg
Division of Vascular Surgery, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
8 shared publications - Germano Melissano
Department of Vascular Surgery, San Raffaele Scientific Institute, Vita-Salute University, Milano, Italy
7 shared publications - Alessandro Grandi
Division of Vascular Surgery, Department of Clinical and Experimental Sciences, School of Medicine, University of Brescia, ASST Spedali Civili of Brescia, 25123 Brescia, Italy
6 shared publications Germano Melissano
5 shared publications
Latest Publications
- 20 November 2026
- Published by SAGE Publications in Journal of Endovascular Therapy
Complex Endovascular Repair for Genetically-Triggered Aortic Disease in Italy (CENTRAL Multicentric Registry)
Background: The role of fenestrated and branched endovascular aortic repair (F/BEVAR) in patients with genetically triggered aortic disease and connective tissue disorders (CTDs) remains controversial due to concerns regarding long-term durability and disease progression. This multicenter study aimed to evaluate early and mid-term outcomes of F/BEVAR in patients with CTD treated for thoracoabdominal aortic aneurysms (TAAAs). Methods: This retrospective multicenter study included all consecutive CTD patients with genetically triggered aortic disease undergoing F/BEVAR for TAAA between 2013 and 2024 at 12 Italian centers. Primary endpoints were technical and clinical success, early and mid-term survival, and major adverse events (MAEs). Secondary endpoints included target vessel instability and the need for reintervention. Survival and freedom from adverse events were estimated using Kaplan-Meier analysis. Results: A total of 45 CTD patients (62.2% male; mean age, 56.4 ± 11.7 years) were treated with F/BEVAR. Marfan syndrome was present in 80% of patients, and 68.9% were treated for post-dissection TAAA. Most patients presented with type II TAAA (91.1%), and 88.9% had undergone at least 1 prior aortic operation. Technical and clinical success were achieved in 86.6% and 82.2% of cases, respectively. Early mortality and MAEs occurred in 4.4% of patients. During a mean clinical follow-up of 35.0 ± 33.9 months, estimated overall survival at 12, 24, and 36 months was 90.0%, 86.7%, and 79.2%, respectively, with no aorta-related deaths. At a mean imaging follow-up of 33.8 ± 32.2 months, target vessel patency was 98.8%. Target vessel instability occurred in 40% of patients, and 42.2% required 1 or more secondary interventions. Reintervention-free survival at 12, 24, and 36 months was 75.6%, 72.4%, and 59.0%, respectively. No baseline, anatomic, or procedural variable independently predicted late adverse outcomes. Conclusions: In this cohort of CTD patients, predominantly treated in complex redo settings, F/BEVAR demonstrated acceptable early and mid-term outcomes. Late adverse events and reinterventions were frequent but consistent with the natural history of CTD-related aortic disease and were not driven by identifiable baseline factors. These findings support the role of F/BEVAR as a valuable approach within a comprehensive, lifelong management strategy for CTD patients rather than as a definitive alternative to open surgery (OS). Clinical Impact: Patients with genetically triggered aortic disease often require multiple interventions throughout their lifetime because of the progressive nature of the underlying aortopathy. In this context, fenestrated/branched endovascular aortic repair (F/BEVAR) should not be considered an alternative to open surgery, but rather a complementary approach within the long-term management of these patients. This multicenter study provides one of the largest dedicated experiences with F/BEVAR in this challenging population, showing that acceptable early and mid-term outcomes can be achieved even in complex redo and post-dissection settings. These findings support the integration of endovascular techniques into individualized, lifelong aortic treatment strategies at experienced centers, acknowledging the need for continued surveillance and secondary interventions.
- 20 November 2026
- Published by SAGE Publications in Journal of Endovascular Therapy
Complex Endovascular Repair for Genetically-Triggered Aortic Disease in Italy (CENTRAL Multicentric Registry)
Background: The role of fenestrated and branched endovascular aortic repair (F/BEVAR) in patients with genetically triggered aortic disease and connective tissue disorders (CTDs) remains controversial due to concerns regarding long-term durability and disease progression. This multicenter study aimed to evaluate early and mid-term outcomes of F/BEVAR in patients with CTD treated for thoracoabdominal aortic aneurysms (TAAAs). Methods: This retrospective multicenter study included all consecutive CTD patients with genetically triggered aortic disease undergoing F/BEVAR for TAAA between 2013 and 2024 at 12 Italian centers. Primary endpoints were technical and clinical success, early and mid-term survival, and major adverse events (MAEs). Secondary endpoints included target vessel instability and the need for reintervention. Survival and freedom from adverse events were estimated using Kaplan-Meier analysis. Results: A total of 45 CTD patients (62.2% male; mean age, 56.4 ± 11.7 years) were treated with F/BEVAR. Marfan syndrome was present in 80% of patients, and 68.9% were treated for post-dissection TAAA. Most patients presented with type II TAAA (91.1%), and 88.9% had undergone at least 1 prior aortic operation. Technical and clinical success were achieved in 86.6% and 82.2% of cases, respectively. Early mortality and MAEs occurred in 4.4% of patients. During a mean clinical follow-up of 35.0 ± 33.9 months, estimated overall survival at 12, 24, and 36 months was 90.0%, 86.7%, and 79.2%, respectively, with no aorta-related deaths. At a mean imaging follow-up of 33.8 ± 32.2 months, target vessel patency was 98.8%. Target vessel instability occurred in 40% of patients, and 42.2% required 1 or more secondary interventions. Reintervention-free survival at 12, 24, and 36 months was 75.6%, 72.4%, and 59.0%, respectively. No baseline, anatomic, or procedural variable independently predicted late adverse outcomes. Conclusions: In this cohort of CTD patients, predominantly treated in complex redo settings, F/BEVAR demonstrated acceptable early and mid-term outcomes. Late adverse events and reinterventions were frequent but consistent with the natural history of CTD-related aortic disease and were not driven by identifiable baseline factors. These findings support the role of F/BEVAR as a valuable approach within a comprehensive, lifelong management strategy for CTD patients rather than as a definitive alternative to open surgery (OS). Clinical Impact: Patients with genetically triggered aortic disease often require multiple interventions throughout their lifetime because of the progressive nature of the underlying aortopathy. In this context, fenestrated/branched endovascular aortic repair (F/BEVAR) should not be considered an alternative to open surgery, but rather a complementary approach within the long-term management of these patients. This multicenter study provides one of the largest dedicated experiences with F/BEVAR in this challenging population, showing that acceptable early and mid-term outcomes can be achieved even in complex redo and post-dissection settings. These findings support the integration of endovascular techniques into individualized, lifelong aortic treatment strategies at experienced centers, acknowledging the need for continued surveillance and secondary interventions.
- 12 June 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (4) , 812-826.e6
Postdissection thoracoabdominal aortic aneurysm presenting with narrow true lumen: Outcomes after fenestrated and branched endovascular repair from the international multicenter NArrow-true-lumen DIssection Registry (NADIR) study group
- 12 June 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (4) , 812-826.e6
Postdissection thoracoabdominal aortic aneurysm presenting with narrow true lumen: Outcomes after fenestrated and branched endovascular repair from the international multicenter NArrow-true-lumen DIssection Registry (NADIR) study group
- Open Access
- 29 November 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (6) , 1048
Endovascular Repair of Gastroduodenal Artery Pseudoaneurysm with Portal Vein Fistula
- 29 November 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (6) , 1048
Open AccessEndovascular Repair of Gastroduodenal Artery Pseudoaneurysm with Portal Vein Fistula
- Open Access
- 3 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6998
Staging Strategies During Complex Endovascular Aortic Procedures to Minimize Spinal Cord Ischemia Rates: A Narrative Review
Endovascular repair of thoracoabdominal aortic aneurysms (TAAAs) requires multidisciplinary expertise to minimize mortality and disabling complications. Despite satisfactory outcomes with this approach being common knowledge, extensive aortic coverage occurring in fenestrated/branched endovascular aortic repair (F/B-EVAR) carries a non-negligible risk of spinal cord ischemia (SCI). Recently, many authors have proposed different endovascular strategies to mitigate the risk of SCI; however, the real effectiveness of these maneuvers is not universally recognized due to a lack of standardized protocols among individual centers. Several adjuncts have been proposed to obtain staged occlusion of segmental aortic branches to promote spinal cord preconditioning. These strategies include proximal thoracic aortic repair (PTAR), temporary aneurysm sac perfusion (TASP), and minimally invasive staged segmental artery coil embolization (MIS2ACE). The present paper aims to provide an overview of the most advanced staging strategies used in high-volume aortic centers, pointing out that it takes meticulous preoperative planning to face every clinical scenario.
- 3 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (19) , 6998
Open AccessStaging Strategies During Complex Endovascular Aortic Procedures to Minimize Spinal Cord Ischemia Rates: A Narrative Review
Endovascular repair of thoracoabdominal aortic aneurysms (TAAAs) requires multidisciplinary expertise to minimize mortality and disabling complications. Despite satisfactory outcomes with this approach being common knowledge, extensive aortic coverage occurring in fenestrated/branched endovascular aortic repair (F/B-EVAR) carries a non-negligible risk of spinal cord ischemia (SCI). Recently, many authors have proposed different endovascular strategies to mitigate the risk of SCI; however, the real effectiveness of these maneuvers is not universally recognized due to a lack of standardized protocols among individual centers. Several adjuncts have been proposed to obtain staged occlusion of segmental aortic branches to promote spinal cord preconditioning. These strategies include proximal thoracic aortic repair (PTAR), temporary aneurysm sac perfusion (TASP), and minimally invasive staged segmental artery coil embolization (MIS2ACE). The present paper aims to provide an overview of the most advanced staging strategies used in high-volume aortic centers, pointing out that it takes meticulous preoperative planning to face every clinical scenario.
- Open Access
- 4 September 2025
- Published by MDPI AG in Preprints.org
Staging Strategies During Complex Endovascular Aortic Procedures to Minimize Spinal Cord Ischemia Rates: A Narrative Review
Endovascular repair of thoracoabdominal aortic aneurysms (TAAAs) requires multidisciplinary expertise to minimize mortality and disabling complications. Despite satisfactory outcomes with this approach being common knowledge, extensive aortic coverage occurring in fenestrated/branched endovascular aortic repair (F/B-EVAR) carries a non-negligible risk of spinal cord ischemia (SCI). Recently, many authors have proposed different endovascular strategies to mitigate the risk of SCI; however, the real effectiveness of these maneuvers is not universally recognized due to a lack of standardized protocols among individual centers. Several adjuncts have been proposed to obtain staged occlusion of segmental aortic branches to promote spinal cord preconditioning. These strategies include proximal thoracic aortic repair (PTAR), temporary aneurysm sac perfusion (TASP), and minimally invasive staged segmental artery coil embolization (MIS2ACE). The present paper aims to provide an overview of the most advanced staging strategies used in high-volume aortic centers, pointing out that it takes meticulous preoperative planning to face every clinical scenario.
- 4 September 2025
- Published by MDPI AG in Preprints.org
Open AccessStaging Strategies During Complex Endovascular Aortic Procedures to Minimize Spinal Cord Ischemia Rates: A Narrative Review
Endovascular repair of thoracoabdominal aortic aneurysms (TAAAs) requires multidisciplinary expertise to minimize mortality and disabling complications. Despite satisfactory outcomes with this approach being common knowledge, extensive aortic coverage occurring in fenestrated/branched endovascular aortic repair (F/B-EVAR) carries a non-negligible risk of spinal cord ischemia (SCI). Recently, many authors have proposed different endovascular strategies to mitigate the risk of SCI; however, the real effectiveness of these maneuvers is not universally recognized due to a lack of standardized protocols among individual centers. Several adjuncts have been proposed to obtain staged occlusion of segmental aortic branches to promote spinal cord preconditioning. These strategies include proximal thoracic aortic repair (PTAR), temporary aneurysm sac perfusion (TASP), and minimally invasive staged segmental artery coil embolization (MIS2ACE). The present paper aims to provide an overview of the most advanced staging strategies used in high-volume aortic centers, pointing out that it takes meticulous preoperative planning to face every clinical scenario.
- 1 September 2025
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 66 (4) , 291-298
Open repair of native and prosthetic aortic infection with pre-sutured or stapled xenopericardial grafts
Aortic Graft Infection (AGI) and Infective Native Aortic Aneurysm (INAA) require open repair with infection-resistant prostheses. Physician's made xeno-pericardial grafts combine availability with freedom from reinfection, but mainly short-term results are reported. The aim is to examine the mid-term outcomes in aortic infections using stapled physician-made or pre-sutured bovine pericardium tube grafts. We report all patients who underwent in situ aortic reconstruction using pericardial tube grafts (prepared from pericardial patches using a surgical stapler or pre-sutured) for AGI or INAA between January 2019 and October 2024 at a single center. Perioperative outcomes and follow-up data were retrospectively collected. Twenty-one patients (18 male, median age 72 years) underwent aortic surgery and implantation of a preformed (N.=5) or stapled physician-made (N.=16) pericardial tubes graft for an INAA (N.=7) or AGI (N.=14). All AGI patients had late infections (median time from primary surgery of 81 months), in nine cases associated with aorto-digestive fistula. One perioperative death was recorded. Patients treated for an AGI demonstrated a longer median length of stay (22 vs. 12 days; P=0.020) and higher intraoperative blood loss (1400 vs. 400 mL; P=0.025). Of the 20 patients surviving the index event, at a mean follow-up of 23±8 months, no aortic-related death, nor mechanical failure were recorded. One case of reinfection and reintervention has been observed (4.8%). All but one patient discontinued the antibiotic therapy after a median duration of 146 days. Aortic repair with preformed and home-made stapled xeno-pericardial grafts is safe and provides durable infection-free survival at a mid-term follow-up.
- 1 September 2025
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 66 (4) , 291-298
Open repair of native and prosthetic aortic infection with pre-sutured or stapled xenopericardial grafts
Aortic Graft Infection (AGI) and Infective Native Aortic Aneurysm (INAA) require open repair with infection-resistant prostheses. Physician's made xeno-pericardial grafts combine availability with freedom from reinfection, but mainly short-term results are reported. The aim is to examine the mid-term outcomes in aortic infections using stapled physician-made or pre-sutured bovine pericardium tube grafts. We report all patients who underwent in situ aortic reconstruction using pericardial tube grafts (prepared from pericardial patches using a surgical stapler or pre-sutured) for AGI or INAA between January 2019 and October 2024 at a single center. Perioperative outcomes and follow-up data were retrospectively collected. Twenty-one patients (18 male, median age 72 years) underwent aortic surgery and implantation of a preformed (N.=5) or stapled physician-made (N.=16) pericardial tubes graft for an INAA (N.=7) or AGI (N.=14). All AGI patients had late infections (median time from primary surgery of 81 months), in nine cases associated with aorto-digestive fistula. One perioperative death was recorded. Patients treated for an AGI demonstrated a longer median length of stay (22 vs. 12 days; P=0.020) and higher intraoperative blood loss (1400 vs. 400 mL; P=0.025). Of the 20 patients surviving the index event, at a mean follow-up of 23±8 months, no aortic-related death, nor mechanical failure were recorded. One case of reinfection and reintervention has been observed (4.8%). All but one patient discontinued the antibiotic therapy after a median duration of 146 days. Aortic repair with preformed and home-made stapled xeno-pericardial grafts is safe and provides durable infection-free survival at a mid-term follow-up.
- Open Access
- 3 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 2084
Plug-Based Embolization Techniques of Aortic Side Branches during Standard and Complex Endovascular Aortic Repair
Vascular plugs are an evolving family of vessel occluders providing a single-device embolization system for large, high-flow arteries. Nitinol mesh plugs and polytetrafluoroethylene membrane plugs are available in different configurations and sizes to occlude arteries from 3 to 20 mm in diameter. Possible applications during complex endovascular aortic procedures are aortic branch embolization to prevent endoleak or to gain an adequate landing zone, directional branch occlusion, and false lumen embolization in aortic dissection. Plugs are delivered through catheters or introducers, and their technical and clinical results are comparable to those of coil embolization. Plugs are more accurate than coils as repositionable devices, less prone to migration, and have fewer blooming artifacts on postoperative computed tomography imaging. Their main drawback is the need for larger delivery systems. This narrative review describes up-to-date techniques and technology for plug embolization in complex aortic repair.
- 3 April 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 2084
Open AccessPlug-Based Embolization Techniques of Aortic Side Branches during Standard and Complex Endovascular Aortic Repair
Vascular plugs are an evolving family of vessel occluders providing a single-device embolization system for large, high-flow arteries. Nitinol mesh plugs and polytetrafluoroethylene membrane plugs are available in different configurations and sizes to occlude arteries from 3 to 20 mm in diameter. Possible applications during complex endovascular aortic procedures are aortic branch embolization to prevent endoleak or to gain an adequate landing zone, directional branch occlusion, and false lumen embolization in aortic dissection. Plugs are delivered through catheters or introducers, and their technical and clinical results are comparable to those of coil embolization. Plugs are more accurate than coils as repositionable devices, less prone to migration, and have fewer blooming artifacts on postoperative computed tomography imaging. Their main drawback is the need for larger delivery systems. This narrative review describes up-to-date techniques and technology for plug embolization in complex aortic repair.
- 7 December 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
An International Expert-Based CONsensus on Indications and Techniques for aoRtic balloOn occLusion in the Management of Ruptured Abdominal Aortic Aneurysms (CONTROL-RAAA)
Objective: To report on the recommendations of an expert-based consensus on the indications, timing, and techniques of aortic balloon occlusion (ABO) in the management of ruptured abdominal aortic aneurysms (rAAA). Methods: Eleven facilitators created appropriate statements regarding the study issues that were voted on using a 4-point Likert scale with open-comment fields, by a selected panel of international experts (vascular surgeons and interventional radiologists) using a 3-round modified Delphi consensus procedure (study period: January-April 2023). Based on the experts’ responses, only the statements reaching grade A (full agreement ≥75%) or B (overall agreement ≥80% and full disagreement <5%) were included in the final study report. The consistency of each round’s answers was also graded using Cohen’s kappa, the intraclass correlation coefficient, and, in case of double resubmission, Fleiss kappa. Results: Sixty-three experts were included in the final analysis and voted on 25 statements related to indication and timing (n=6), and techniques (n=19) of ABO in the setting of rAAA. Femoral sheath or ABO should be preferably placed in the operating room, via a percutaneous transfemoral access, on a stiff wire (grade B, consistency I), ABO placement should be suprarenal and last less than 30 minutes (grade B, consistency II), postoperative peripheral vascular status (grade A, consistency II) and laboratory testing every 6 to 12 hours (grade B, consistency) should be assessed to detect complications. Formal training for ABO should be implemented (grade B, consistency I). Most of the statements in this international expert-based Delphi consensus study might guide current choices for indications, timing, and techniques of ABO in the management of rAAA. Clinical practice guidelines should incorporate dedicated statements that can guide clinicians in decision-making. Conclusions: At arrival and during both open or endovascular procedures for rAAA, selective use of intra-aortic balloon occlusion is recommended, and it should be performed preferably by the treating physician in aortic pathology. Clinical Impact: This is the first consensus study of international vascular experts aimed at defining the indications, timing, and techniques of optimal use of ABO in the clinical setting of rAAA. Aortic occlusion by endovascular means (or ABO) is a quick procedure in properly trained hands that may play an important role as a temporizing measure until the definitive aortic repair is achieved, whether by endovascular or open means. Since data on its use in hemodynamically unstable patients are limited in the literature, owing to practical challenges in the performance of well-conducted prospective studies, understanding real-world use by experts is of importance in addressing critical issues and identifying main gaps in knowledge.
- 7 December 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
An International Expert-Based CONsensus on Indications and Techniques for aoRtic balloOn occLusion in the Management of Ruptured Abdominal Aortic Aneurysms (CONTROL-RAAA)
Objective: To report on the recommendations of an expert-based consensus on the indications, timing, and techniques of aortic balloon occlusion (ABO) in the management of ruptured abdominal aortic aneurysms (rAAA). Methods: Eleven facilitators created appropriate statements regarding the study issues that were voted on using a 4-point Likert scale with open-comment fields, by a selected panel of international experts (vascular surgeons and interventional radiologists) using a 3-round modified Delphi consensus procedure (study period: January-April 2023). Based on the experts’ responses, only the statements reaching grade A (full agreement ≥75%) or B (overall agreement ≥80% and full disagreement <5%) were included in the final study report. The consistency of each round’s answers was also graded using Cohen’s kappa, the intraclass correlation coefficient, and, in case of double resubmission, Fleiss kappa. Results: Sixty-three experts were included in the final analysis and voted on 25 statements related to indication and timing (n=6), and techniques (n=19) of ABO in the setting of rAAA. Femoral sheath or ABO should be preferably placed in the operating room, via a percutaneous transfemoral access, on a stiff wire (grade B, consistency I), ABO placement should be suprarenal and last less than 30 minutes (grade B, consistency II), postoperative peripheral vascular status (grade A, consistency II) and laboratory testing every 6 to 12 hours (grade B, consistency) should be assessed to detect complications. Formal training for ABO should be implemented (grade B, consistency I). Most of the statements in this international expert-based Delphi consensus study might guide current choices for indications, timing, and techniques of ABO in the management of rAAA. Clinical practice guidelines should incorporate dedicated statements that can guide clinicians in decision-making. Conclusions: At arrival and during both open or endovascular procedures for rAAA, selective use of intra-aortic balloon occlusion is recommended, and it should be performed preferably by the treating physician in aortic pathology. Clinical Impact: This is the first consensus study of international vascular experts aimed at defining the indications, timing, and techniques of optimal use of ABO in the clinical setting of rAAA. Aortic occlusion by endovascular means (or ABO) is a quick procedure in properly trained hands that may play an important role as a temporizing measure until the definitive aortic repair is achieved, whether by endovascular or open means. Since data on its use in hemodynamically unstable patients are limited in the literature, owing to practical challenges in the performance of well-conducted prospective studies, understanding real-world use by experts is of importance in addressing critical issues and identifying main gaps in knowledge.
- 30 November 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (5) , 737
Regress with Progress: Look for Shrinkage after B/F-EVAR with the Eye of Artificial Intelligence
- 30 November 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (5) , 737
Regress with Progress: Look for Shrinkage after B/F-EVAR with the Eye of Artificial Intelligence
- 26 September 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 32 (4) , 1075-1082
Outcomes of Percutaneous Access to the First Versus Third Segment of Axillary Artery During Aortic Procedures
Purpose: This article aims at investigating the outcomes of percutaneous access via the first versus third axillary artery (AXA) segments with closure devices during aortic procedures. Materials and Methods: All patients receiving percutaneous AXA access closed with Perclose ProGlide device (Abbott, Santa Clara, California) from 2008 to 2021 were included in a retrospective multicenter registry (NCT: 04589962). Efficacy endpoint was the technically successful percutaneous procedure (no open conversion). Safety endpoints were stroke and access complications according to the Valve Academic Research Consortium-3 reporting standards. The first (AXA1) or third (AXA3) axillary puncture sites were compared. Results: A total of 412 percutaneous AXA accesses were included: 172 (42%) in AXA1 and 240 (58%) in AXA3. Left AXA was catheterized in 363 cases (76% of AXA1 vs 97% of AXA3, p36 months of follow-up. Stroke rate was 4.4%. An introducer sheath >12F was independently associated with both access complications (p10F introducer sheath provided worse outcomes compared with >10F sheaths through AXA1 (OR for success=0.367, 95% CI=0.176–0.767, p=0.008). This was not confirmed for >12F sheaths, associated with similar outcomes (p=0.31 AXA 1 vs AXA 3). Conclusion: Major local complications with the percutaneous axillary approach and ≤12F sheaths are infrequent and solvable by complementary endovascular interventions. Stroke risk remains an issue. First and third AXA segments are both amenable for access with good results, but larger sheaths (12F) perform better in AXA1. Clinical Impact: Percutaneous access with vascular closure devices at the first or third axillary artery (AXA) segments during aortic procedures is burdened by a negligible risk of open conversion. Local complications with the percutaneous axillary approach are infrequent and solvable by complementary endovascular interventions. First and third AXA segments are both amenable to access with excellent results, but larger sheaths (12F) perform better in the wider first AXA segment. In this setting, bailout stenting does not appear to be associated with mid-term stent occlusion.
- 26 September 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 32 (4) , 1075-1082
Outcomes of Percutaneous Access to the First Versus Third Segment of Axillary Artery During Aortic Procedures
Purpose: This article aims at investigating the outcomes of percutaneous access via the first versus third axillary artery (AXA) segments with closure devices during aortic procedures. Materials and Methods: All patients receiving percutaneous AXA access closed with Perclose ProGlide device (Abbott, Santa Clara, California) from 2008 to 2021 were included in a retrospective multicenter registry (NCT: 04589962). Efficacy endpoint was the technically successful percutaneous procedure (no open conversion). Safety endpoints were stroke and access complications according to the Valve Academic Research Consortium-3 reporting standards. The first (AXA1) or third (AXA3) axillary puncture sites were compared. Results: A total of 412 percutaneous AXA accesses were included: 172 (42%) in AXA1 and 240 (58%) in AXA3. Left AXA was catheterized in 363 cases (76% of AXA1 vs 97% of AXA3, p36 months of follow-up. Stroke rate was 4.4%. An introducer sheath >12F was independently associated with both access complications (p10F introducer sheath provided worse outcomes compared with >10F sheaths through AXA1 (OR for success=0.367, 95% CI=0.176–0.767, p=0.008). This was not confirmed for >12F sheaths, associated with similar outcomes (p=0.31 AXA 1 vs AXA 3). Conclusion: Major local complications with the percutaneous axillary approach and ≤12F sheaths are infrequent and solvable by complementary endovascular interventions. Stroke risk remains an issue. First and third AXA segments are both amenable for access with good results, but larger sheaths (12F) perform better in AXA1. Clinical Impact: Percutaneous access with vascular closure devices at the first or third axillary artery (AXA) segments during aortic procedures is burdened by a negligible risk of open conversion. Local complications with the percutaneous axillary approach are infrequent and solvable by complementary endovascular interventions. First and third AXA segments are both amenable to access with excellent results, but larger sheaths (12F) perform better in the wider first AXA segment. In this setting, bailout stenting does not appear to be associated with mid-term stent occlusion.